Authorisation of human medicinal products with new active substances and of additional indications 2020

In 2020, despite the extraordinary amount of work generated by the pandemic, Swissmedic assessed a record number of medicinal products with new active substances and authorised them for distribution on the Swiss market. In this brochure you can see which procedures the applicants used, how long the authorisation processes lasted, and for which indications the medicines were approved.